Knowde Enhanced TDS
Identification & Functionality
- Chemical Family
- Fluids & Lubricants Functions
- Technologies
- Product Families
Features & Benefits
- Fluids & Lubricants Features
- Highly-Refined Paraffinic Process Oils
Providing excellent color stability without sacrificing elastomer compatibility and process characteristics, the CALSOL P9 Series is aligned to current elastomeric rubber industry standards.
- Low Volatility
- Moderate Aniline Points
- Very Low Polar Compound Levels
The CALSOL P9 Series is available in a wide range of viscosities and exhibit the balance of properties that also make them the preferred choice for non-rubber applications such as EPDM Compounding, PVC, textiles, and caulking compounds.
Applications & Uses
- Markets
- Compatible Substrates & Surfaces
Properties
- Physical Properties
Value | Units | Test Method / Conditions | |
Carbon Type Analysis (Ca) | 0 | % | ASTM D2140 |
Carbon Type Analysis (Cn) | 36 | % | ASTM D2140 |
Carbon Type Analysis (Cp) | 64 | % | ASTM D2140 |
Clay-Gel Aromatics Content | 9.4 | wt% | ASTM D2007 |
Clay-Gel Asphaltenes Content | 0 | wt% | ASTM D2007 |
Clay-Gel Polar Compounds | 0 | wt% | ASTM D2007 |
Clay-Gel Saturates Content | 90.6 | wt% | ASTM D2007 |
Color | 1 | — | ASTM D1500 |
Flash Point | 402 | °F | ASTM D92 |
Molecular Weight | 365 | — | ASTM D2502 |
Pour Point | 5 | °F | ASTM D97 |
Refractive Index | 1.4698 | — | ASTM D1747 |
Specific Gravity, (60°F, 15°C) | 0.8575 | — | ASTM D1250 |
UV Absorptivity / 260 NM | 0.1 | — | ASTM D2008 |
Viscosity (at 100°C) | 4.1 | cSt | ASTM D445 |
Viscosity (at 100°F) | 105.7 | SUS | ASTM D2161 |
Viscosity (at 210°F) | 39.9 | SUS | ASTM D2161 |
Viscosity (at 40°C) | 20.1 | cSt | ASTM D445 |
Viscosity-Gravity Constant | 0.809 | — | ASTM D2501 |
Aniline Point | 220.7 | °F | ASTM D611 |
Volatility Content (at 225°F) | 2.1 | wt% | ASTM D972 |
API Gravity (at 60°F, 15°C) | 33.5 | — | ASTM D287 |
Weight | 7.1498 | lb/gal | ASTM D1250 |
Regulatory & Compliance
- Certifications & Compliance
- FDA Regulations
Complies with
FDA-21 CFR 178.3620 (c)